GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Net Change in Cash

Sphere Medical Holding (LSE:SPHR) Net Change in Cash : £-6.79 Mil (TTM As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Sphere Medical Holding's Net Change in Cash for the six months ended in Dec. 2016 was £-3.40 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2016 was £-6.79 Mil.

Sphere Medical Holding Net Change in Cash Historical Data

The historical data trend for Sphere Medical Holding's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Net Change in Cash Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only -3.21 6.37 -5.55 6.33 -6.79

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -2.62 9.05 -2.72 -3.39 -3.40

Sphere Medical Holding Net Change in Cash Calculation

Sphere Medical Holding's Net Change in Cash for the fiscal year that ended in Dec. 2016 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-4.521+-2.195+-0.071+0
=-6.79

Sphere Medical Holding's Net Change in Cash for the quarter that ended in Dec. 2016

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-2.452+-0.944+0+0
=-3.40

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-6.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sphere Medical Holding Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Net Change in Cash
Comparable Companies
LSE:MED LSE:DEMG EVAR LSE:CPT LSE:AVO LSE:IHC LSE:LID ASX:AVH FGCN LSE:SUN LSE:AVCT LSE:BQE LSE:CREO LSE:KMK LSE:IDH LSE:MGP LSE:CSRT NMRD LIVN LSE:CTEC
Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Website
http://www.spheremedical.com
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.